What is the Kolon TissueGene stock price forecast?

Kolon TissueGene is currently trading at ₩127,800. View real-time AI analysis on Alpha Lenz.

What is Kolon TissueGene insider trading activity?

View the latest insider trading data for Kolon TissueGene on Alpha Lenz.

What is Kolon TissueGene's P/E ratio?

Kolon TissueGene's P/E ratio is -56.2.

Kolon TissueGene

KRX · 950160

₩127,800+13,200(+11.52%)Market closed

Ask about Kolon TissueGene's future dividend policy...

Alpha Chat Insight

“Kolon TissueGene trades at a P/E of -56.2 (undervalued) with modest ROE of -183.4%.”

Ask for details →

Company Overview

CEO노문종, 전승호

Websitehttps://www.tissuegene.com

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩10,829,267,190,000Market Cap

₩5,158,705,000Revenue

84.74MShares Out

0Employees

Margins

13.28%Gross

-408.88%EBITDA

-432.73%Operating

-3732.85%Pre-Tax

-3733.25%Net

Valuation

-56.23P/E

168.99P/B

2099.22EV/Sales

-513.96EV/EBITDA

-76.54P/FCF

Growth (CAGR)

-18.29%Rev 3Yr

7.73%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-59.60%ROA

-183.43%ROE

-59.56%ROIC

Financial Health

₩67,742,227,000Cash & Cash Equivalents

₩292,167,012,000Net Debt

561.65%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Kolon TissueGene trades at a P/E of -56.2 (undervalued) with modest ROE of -183.4%.”

Ask for details →

Frequently Asked Questions

Kolon TissueGene (ticker: 950160) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $10.8T.

The current price is ₩127,800 with a P/E ratio of -56.23x and P/B of 168.99x.

ROE is -183.43% and operating margin is -432.73%. Annual revenue is $5.2B.